In human and experimental glomerulonephritis, glomerular hypercellularity results both from accumulation of macrophages and proliferation of resident glomerular cells. The recent identification of macrophage-derived factors that stimulate mesangial and epithelial cell proliferation suggests that these factors might contribute to the hypercellularity. To determine the identity of such macrophage-derived growth factors, we studied the effect of leukotrienes (LTs) 
Introduction
In human and experimental glomerulonephritis, glomerular hypercellularity results both from infiltration by cells of the monocyte-macrophage series and from proliferation of the resident endothelial, epithelial, and mesangial cells (1) (2) (3) (4) (5) . Although the precise stimuli for this cellular proliferation are largely unknown, it has been hypothesized that the glomerular Received for publication 29 November 1984 and in revised form 8 April 1985. cell division results from the secretion of growth factors by the infiltrating mononuclear cells (6, 7) . Indeed, the endothelial cell hyperplasia that occurs in experimental glomerulonephritis depends on the local infiltration by macrophages, as demonstrated in studies using anti-macrophage serum (8) . Moreover, the proliferation of mesangial or epithelial cells in culture is enhanced by macrophage-derived factors (9) (10) (11) . The stimulation of mesangial cell proliferation has been attributed to macrophage interleukin-I (12) , but the identity of the macrophage-derived factor(s) that increase the growth of epithelial cells is still unknown (11) . The purpose of the present study was to determine whether leukotrienes (LTs),' a class of compounds released characteristically by human mononuclear leukocytes (13) (20) , and increased vascular permeability in vivo (21) .
i)
The effect of LTC4 on epithelial cell proliferation was counteracted by the LT antagonist FPL 55712. Such a characteristic of LTC4 activity has been described previously in the whole kidney in studies in which the vasoconstriction induced by LTC4 infusion in vivo was also abolished by FPL 55712 (22) . 
